PUGLIESE, NOVELLA
 Distribuzione geografica
Continente #
AS - Asia 2.798
NA - Nord America 2.193
EU - Europa 1.757
SA - Sud America 329
AF - Africa 86
OC - Oceania 8
Totale 7.171
Nazione #
US - Stati Uniti d'America 2.101
SG - Singapore 1.105
RU - Federazione Russa 818
CN - Cina 581
VN - Vietnam 578
IT - Italia 415
BR - Brasile 254
HK - Hong Kong 206
DE - Germania 127
FR - Francia 94
NL - Olanda 68
BD - Bangladesh 59
GB - Regno Unito 56
JP - Giappone 50
IN - India 49
CA - Canada 46
FI - Finlandia 45
KR - Corea 35
CI - Costa d'Avorio 34
MX - Messico 30
AR - Argentina 25
IE - Irlanda 24
SE - Svezia 23
TH - Thailandia 19
EC - Ecuador 17
IQ - Iraq 17
PL - Polonia 17
ZA - Sudafrica 17
AT - Austria 15
TR - Turchia 15
PH - Filippine 14
UA - Ucraina 13
TW - Taiwan 10
CO - Colombia 8
ID - Indonesia 8
PK - Pakistan 8
CZ - Repubblica Ceca 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
ES - Italia 6
LT - Lituania 6
MA - Marocco 6
NP - Nepal 6
CL - Cile 5
PE - Perù 5
PY - Paraguay 5
AU - Australia 4
EG - Egitto 4
IL - Israele 4
KE - Kenya 4
RS - Serbia 4
TN - Tunisia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
PA - Panama 3
PT - Portogallo 3
SA - Arabia Saudita 3
SC - Seychelles 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BW - Botswana 2
BY - Bielorussia 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
NC - Nuova Caledonia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
Totale 7.167
Città #
Singapore 562
San Jose 461
Moscow 209
Hong Kong 198
Ashburn 197
Chandler 193
Beijing 168
Ho Chi Minh City 165
Hefei 147
Hanoi 118
Naples 99
Santa Clara 87
Los Angeles 66
Amsterdam 58
Munich 50
Lauterbourg 49
Council Bluffs 46
Dong Ket 46
The Dalles 45
Tokyo 44
Dallas 43
Millbury 34
New York 34
Buffalo 31
Seoul 31
Napoli 30
Frankfurt am Main 28
Seattle 27
São Paulo 26
Des Moines 24
Boston 21
Denver 20
Da Nang 19
Haiphong 19
Lawrence 19
London 15
Montreal 15
Poplar 15
Princeton 15
Helsinki 14
Mexico City 14
Turku 14
Nanjing 13
Orem 12
Atlanta 11
Chicago 11
Kochi 11
Milan 11
Phoenix 11
Redondo Beach 11
Warsaw 11
Bangkok 10
Wilmington 10
Brooklyn 9
Guayaquil 9
Nuremberg 9
Rio de Janeiro 9
Toronto 9
Chennai 8
Dublin 8
Nocera Inferiore 8
Ottawa 8
Rome 8
Shanghai 8
Stockholm 8
Tianjin 8
Turin 8
Biên Hòa 7
Houston 7
Hải Dương 7
Lappeenranta 7
Thái Bình 7
Ankara 6
Can Tho 6
Düsseldorf 6
Nanchang 6
Norwalk 6
Rose 6
Roubaix 6
San Francisco 6
Washington 6
Baghdad 5
Bengaluru 5
Calgary 5
Campinas 5
Falkenstein 5
Johannesburg 5
Mondragone 5
Mumbai 5
Porto Alegre 5
Pune 5
Salvador 5
Tashkent 5
Vienna 5
Vĩnh Long 5
Afragola 4
Baku 4
Belo Horizonte 4
Brasília 4
Bắc Giang 4
Totale 3.934
Nome #
Secondary syphilis mimicking malignancy: A case report and review of literature 213
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 187
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison 184
Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL 179
(1-3)-β-d-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations 175
Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21 173
Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Study 172
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma 170
A Novel Score to Predict Interferon-Alpha Therapy Responsiveness in Patients with Essential Thrombocythemia 168
Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma 161
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience 158
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma 153
Advanced-stage Hodgkin Lymphoma: US/Chest Radiography for Detection of Relapse in Patients in First Complete Remission—A Randomized Trial of Routine Surveillance Imaging Procedures 152
MOLECULAR EVALUATION OF ZNF224 MRNA EXPRESSION IN CML PATIENTS AS A NOVEL DETERMINANT OF TKI RESPONSIVENESS 152
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 150
Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1,3-β-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography 150
Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma 149
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial 146
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 143
Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET) 143
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support 140
Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian study 138
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 138
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 136
Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury 135
Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease 135
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib 134
Rituximab-containing risk-adapted treatment strategy in nodular lymphocyte predominant hodgkin lymphoma: 7-years follow-up 131
Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia 131
Involvement of Helicobacter Pylori in Ocular Adnexa Lymphoma 130
Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma - a global view'. Br J Haematol. 2020;190:837-50 128
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 126
Sulfur Exafluoride Contrast-Enhanced Ultrasound Showing Early Wash-Out of Marked Degree Identifies Lymphoma Invasion of Spleen with Excellent Diagnostic Accuracy: A Monocentric Study of 260 Splenic Nodules 117
Cyclic Neutropenia Mimicking Crohn's Disease: Two Case Reports and a Narrative Review 115
Long-term Cryopreserved Autologous Hematopoietic Stem Cells Following Azacytidine to Successfully Treat Severe Invasive Pulmonary Aspergillosis After Therapy-Related Myelodysplastic Syndrome and CD8+ T-cell Autoimmune Disorders: A Case Report 112
Correspondence in reference to previously published manuscript: "Faouzi Djebbari et al. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma. Eur J Haematol 2020; 105: 667-671." 111
Reply to the letter to the editor "chronic disseminated candidiasis" by Kenneth Rolston 109
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis 107
Regarding "Hepatitis B surface antigen positivity is an independent unfavorable prognostic factor in diffuse large B-cell lymphoma in the rituximab era" 107
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study 106
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome 105
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 105
Randomized Comparison of Power Doppler Ultrasonography-Guided Core-Needle Biopsy with Open Surgical Biopsy for the Characterization of Lymphadenopathies in Patients with Suspected Lymphoma, 104
Correspondence in reference to the previously published Epub manuscript: “Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677” 103
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study 101
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy 99
Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma 99
Consolidation radiotherapy following positron emission tomography complete response in early-stage Hodgkin lymphoma: a meta-analysis 99
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis 98
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome 95
Ultrasonography-guided core-needle biopsy for newly diagnosed large b-cell lymphomas: Analysis on Diagnostic efficacy and safety in a Italian retrospective study. 93
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 83
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia 70
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers 66
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 52
Spleen volume assessment in Ph-negative chronic myeloproliferative neoplasms: a real-life study comparing ultrasonography vs. magnetic resonance imaging scans 46
Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin–bleomycin–vinblastine–dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study 39
Routine imaging surveillance after frontline ABVD improves outcome in high-risk hodgkinn lymphoma 38
Targeted Therapy for a Rare PDGFRB-Rearranged Myeloproliferative Neoplasm: A Case Report. 36
Thrombotic complications of central venous catheterization with peripherally inserted catheters in patients with classical‐Hodgkin lymphoma 25
Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline‐induced cardiomyopathy in elderly patients with Hodgkin lymphoma 3
Elastography Enhances the Diagnostic Performance of Conventional Ultrasonography in Differentiating Benign from Malignant Superficial Lymphadenopathies 3
The progression at 24 months (POD24) induces a high risk of transformation of follicular lymphoma: A systematic biopsy verification 3
Lipegfilgrastim for primary prophylaxis of febrile neutropenia in patients treated for advanced-stage classical hodgkin lymphoma: successful outcomes from a multicenter cohort study 2
Totale 7.331
Categoria #
all - tutte 21.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.073


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022278 4 3 11 1 5 14 9 5 21 20 111 74
2022/2023458 34 40 23 18 68 45 7 53 78 63 17 12
2023/2024265 11 32 26 21 13 26 5 59 4 8 34 26
2024/20251.794 56 25 6 22 47 120 173 133 109 239 706 158
2025/20264.126 368 315 453 358 688 130 472 238 494 345 213 52
Totale 7.331